Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Research Article
Nature Biotechnology  17, 456 - 461 (1999)
doi:10.1038/8632

Production of goats by somatic cell nuclear transfer

Alexander Baguisi2, 3, 6, Esmail Behboodi1, 6, David T. Melican1, Julie S. Pollock4, Margaret M. Destrempes1, Christine Cammuso1, Jennifer L. Williams1, Scott D. Nims1, Catherine A. Porter1, Patricia Midura1, Monica J. Palacios2, 3, Sandra L. Ayres3, Richard S. Denniston5, Michael L. Hayes4, Carol A. Ziomek1, Harry M. Meade1, Robert A. Godke5, William G. Gavin1, Eric W. Overström2, 3 & Yann Echelard1

1  Genzyme Transgenics Corporation, Framingham MA, 01701-9322.

2  Nuclear Transfer Laboratory, North Grafton , MA 01356 and

3  Department of Biomedical Sciences, Tufts University School of Veterinary Medicine, North Grafton, MA 01356.

4  Cell and Protein Therapeutic Department, Genzyme Corporation , Framingham, MA 01701-9322.

5  Department of Animal Science, Lousiana State University , Baton Rouge, LA 70803.

6  These authors contributed equally to this work.

Correspondence should be addressed to Eric W. Overström eoverstrom@infonet.tufts.edu or Yann Echelard yechelard@genzyme.com.
nuclear transferoocytetransgenicantithrombin IIIgoat
In this study, we demonstrate the production of transgenic goats by nuclear transfer of fetal somatic cells. Donor karyoplasts were obtained from a primary fetal somatic cell line derived from a 40-day transgenic female fetus produced by artificial insemination of a nontransgenic adult female with semen from a transgenic male. Live offspring were produced with two nuclear transfer procedures. In one protocol, oocytes at the arrested metaphase II stage were enucleated, electrofused with donor somatic cells, and simultaneously activated. In the second protocol, activated in vivo oocytes were enucleated at the telophase II stage, electrofused with donor somatic cells, and simultaneously activated a second time to induce genome reactivation. Three healthy identical female offspring were born. Genotypic analyses confirmed that all cloned offspring were derived from the donor cell line. Analysis of the milk of one of the transgenic cloned animals showed high-level production of human antithrombin III, similar to the parental transgenic line.

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

naturejobs

Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1999 Nature Publishing Group | Privacy policy